Home > Journals > Minerva Cardiology and Angiology > Past Issues > Minerva Cardiology and Angiology 2022 June;70(3) > Minerva Cardiology and Angiology 2022 June;70(3):403-11

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE  DIABETES AND HEART FAILURE 

Minerva Cardiology and Angiology 2022 June;70(3):403-11

DOI: 10.23736/S2724-5683.21.05815-4

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Premature ventricular complex site of origin and ablation outcomes in patients with diabetes mellitus

Francesco DE SENSI 1, Diego PENELA 2, David SOTO-IGLESIAS 2, Beatriz JAUREGUI 2, Rodolfo SAN ANTONIO 2, Juan ACOSTA 3, Juan FERNÀNDEZ-ARMENTA 4, Antonio BERRUEZO 2

1 Misericordia Hospital, Estav Toscana SudEst, Grosseto, Italy; 2 Teknon Medical Center, Heart Institute, Barcelona, Spain; 3 Virgen del Rocío University Hospital, Sevilla, Spain; 4 Puerta del Mar Hospital, Cadiz, Spain



BACKGROUND: Premature ventricular complexes (PVCs) are frequent in patients with diabetes mellitus (DM). Still, the PVCs characteristics as well as the outcomes after catheter ablation in this population remain unknown. Aim of the study was to describe principal features of PVCs ablated in a wide DM-patients cohort and report postablation clinical outcomes in the follow-up of patients with DM and left ventricular dysfunction.
METHODS: From April 2012 to April 2020 data of 544 patients (315 [58%] men, 55±16 y), consecutive patients submitted for PVC ablation, were prospectively collected. Patients with left ventricle (LV) systolic disfunction (LVEF<50%) were included in a prospective protocol and followed at 6 and 12 months, and annually thereafter. Baseline characteristic as well ablation outcomes were analyzed based on the presence of DM.
RESULTS: Sixty (11%) patients had DM. Patients with DM more frequently had a PVC’s site of origin (SOO) in the LV (45 [75%] vs. 229 [48%], P<0.001). The most frequent PVC’s SOO in DM patients was the LV outflow tract (OT) (35 [58%] patients: 12 aortic cusps; 12 LV summit; 11 in the myocardium immediately inferior to the valvular plane). Fifty-five (92%) patients with DM had an acute successful ablation, without differences compared with patients without DM (55 [92%] vs. 437 [90%], P=0.9). Twenty-tree (38%) DM-patients had LV dysfunction at the ablation time. In these patients, mean PVC burden decreased from 26±11% at baseline to 4±5% (P<0.001); LVEF increased from 36±8% to 42±11% (P<0.01) and NYHA class improved from 2.2±0.6 to 1.8+0.5 (P<0.01), after a mean follow-up of 37±14 months.
CONCLUSIONS: Patients with DM frequently have PVC with a LV-SOO, being the LVOT the most frequent SOO in this population. Among DM patients with LV dysfunction, ablation persistently and significantly reduce the PVC burden improving functional status. Patients with DM have lower benefit in terms of LV function recovery after ablation compared with non-diabetic patients.


KEY WORDS: Ablation techniques; Diabetes mellitus; Ventricular dysfunction, left; Ventricular premature complexes; Heart failure

top of page